Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
thymosin beta-4 (1 trial)
Dry Eye Syndromes (Phase 2)
Graft vs Host Disease (Phase 2)
Keratoconjunctivitis Sicca (Phase 2)
Sjogren's Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)